Dr. Joseph Kozikowski will present on operational excellence at the annual BD Global Regulatory Leadership Team Conference.
NATICK, MA – October 16, 2009 – Clinivation, Inc. announced today that clinivation Founder and CEO Joseph Kozikowski, M.D. will present to the BD Global Regulatory Leadership Team.
As an authority on the development and commercialization of advanced medical technology, and having led thousands of new submissions, renewals, refilings, novated submissions for major multinationals worldwide, Dr. Kozikowski will share his perspectives in a presentation entitled “Achieving Excellence in Global Market Clearance Operations.”
The presentation will address innovative approaches and important industry best practices, and will include discussions on value creation, effective governance, and enabling execution with information technology.
Dr. Kozikowski will also serve as Panel Chair, and he will be joined by other clinivation thought leaders.
The audience will include BD regulatory affairs, legal, and other executive leadership. The presentation will be held in conjunction with the Annual BD Global Regulatory Leadership Team Conference on November 2, 2009 at the BD Infusion Therapy Global Headquarters, Sandy, UT.
Following the presentation, Dr. Kozikowski will be available for discussions and meetings to discuss the topics in greater depth.
Quotes & Commentary:
“It is an honor to have been invited to present, and I thank the BD executive leadership for their efforts in arranging this opportunity for international learning,” said clinivation Founder and CEO Joseph Kozikowski, M.D.
About BD:
BD is a leading global medical technology company that develops, manufactures and sells medical devices, instrument systems and reagents. The Company is dedicated to improving people’s health throughout the world. BD is focused on improving drug delivery, enhancing the quality and speed of diagnosing infectious diseases and cancers, and advancing research, discovery and production of new drugs and vaccines. BD’s capabilities are instrumental in combating many of the world’s most pressing diseases. Founded in 1897 and headquartered in Franklin Lakes, New Jersey, BD employs approximately 29,000 associates in approximately 50 countries throughout the world. The Company serves healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry and the general public.
